Updated: FDA slaps Optum Infusion with a warning letter over 'insanitary' production conditions
The FDA issued a warning letter to Optum Infusion Services last month citing a list of potential contamination concerns, including “vermin” found in a production …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.